221 related articles for article (PubMed ID: 30373803)
1. Emergence of Resistance to Macrolides and Rifampin in Clinical Isolates of Rhodococcus equi from Foals in Central Kentucky, 1995 to 2017.
Huber L; Giguère S; Slovis NM; Carter CN; Barr BS; Cohen ND; Elam J; Erol E; Locke SJ; Phillips ED; Smith JL
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373803
[TBL] [Abstract][Full Text] [Related]
2. Determination of the prevalence of antimicrobial resistance to macrolide antimicrobials or rifampin in Rhodococcus equi isolates and treatment outcome in foals infected with antimicrobial-resistant isolates of R equi.
Giguère S; Lee E; Williams E; Cohen ND; Chaffin MK; Halbert N; Martens RJ; Franklin RP; Clark CC; Slovis NM
J Am Vet Med Assoc; 2010 Jul; 237(1):74-81. PubMed ID: 20590498
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors associated with emergence of Rhodococcus equi resistance to macrolides and rifampicin in horse-breeding farms in Kentucky, USA.
Huber L; Giguère S; Cohen ND; Slovis NM; Hanafi A; Schuckert A; Berghaus L; Greiter M; Hart KA
Vet Microbiol; 2019 Aug; 235():243-247. PubMed ID: 31383308
[TBL] [Abstract][Full Text] [Related]
4. Mutant prevention concentration and mutant selection window for 10 antimicrobial agents against Rhodococcus equi.
Berghaus LJ; Giguère S; Guldbech K
Vet Microbiol; 2013 Oct; 166(3-4):670-5. PubMed ID: 23915992
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Resistance in
Giguère S; Berghaus LJ; Willingham-Lane JM
Microbiol Spectr; 2017 Oct; 5(5):. PubMed ID: 29052538
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial susceptibility patterns of Rhodococcus equi from necropsied foals with rhodococcosis.
Erol E; Locke S; Saied A; Cruz Penn MJ; Smith J; Fortner J; Carter C
Vet Microbiol; 2020 Mar; 242():108568. PubMed ID: 32122582
[TBL] [Abstract][Full Text] [Related]
7. Identification of macrolide- and rifampicin-resistant Rhodococcus equi in environmental samples from equine breeding farms in central Kentucky during 2018.
Huber L; Giguère S; Cohen ND; Slovis NM; Berghaus L; Greiter M; Hart KA
Vet Microbiol; 2019 May; 232():74-78. PubMed ID: 31030848
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Infections Caused by Rhodococcus equi.
Giguère S
Vet Clin North Am Equine Pract; 2017 Apr; 33(1):67-85. PubMed ID: 28161038
[TBL] [Abstract][Full Text] [Related]
9. Macrolide- and rifampin-resistant Rhodococcus equi on a horse breeding farm, Kentucky, USA.
Burton AJ; Giguère S; Sturgill TL; Berghaus LJ; Slovis NM; Whitman JL; Levering C; Kuskie KR; Cohen ND
Emerg Infect Dis; 2013 Feb; 19(2):282-5. PubMed ID: 23347878
[TBL] [Abstract][Full Text] [Related]
10. Emergence of rifampin-resistant Rhodococcus equi in an infected foal.
Takai S; Takeda K; Nakano Y; Karasawa T; Furugoori J; Sasaki Y; Tsubaki S; Higuchi T; Anzai T; Wada R; Kamada M
J Clin Microbiol; 1997 Jul; 35(7):1904-8. PubMed ID: 9196223
[TBL] [Abstract][Full Text] [Related]
11. Effect of Macrolide and Rifampin Resistance on the Fitness of Rhodococcus equi.
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Appl Environ Microbiol; 2019 Apr; 85(7):. PubMed ID: 30683740
[No Abstract] [Full Text] [Related]
12. Effect of Macrolide and Rifampin Resistance on Fitness of
Willingham-Lane JM; Berghaus LJ; Berghaus RD; Hart KA; Giguère S
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331959
[TBL] [Abstract][Full Text] [Related]
13. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia.
Giguère S; Jacks S; Roberts GD; Hernandez J; Long MT; Ellis C
J Vet Intern Med; 2004; 18(4):568-73. PubMed ID: 15320600
[TBL] [Abstract][Full Text] [Related]
14. In vitro synergy, pharmacodynamics, and postantibiotic effect of 11 antimicrobial agents against Rhodococcus equi.
Giguère S; Lee EA; Guldbech KM; Berghaus LJ
Vet Microbiol; 2012 Nov; 160(1-2):207-13. PubMed ID: 22704561
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mutations in the rpoB gene associated with rifampin resistance in Rhodococcus equi isolated from foals.
Fines M; Pronost S; Maillard K; Taouji S; Leclercq R
J Clin Microbiol; 2001 Aug; 39(8):2784-7. PubMed ID: 11473992
[TBL] [Abstract][Full Text] [Related]
16. Association between antimicrobial treatment of subclinical pneumonia in foals and selection of macrolide- and rifampicin-resistant
Huber L; Giguère S; Hart KA; Slovis NM; Greiter ME; Dailey CA; Cohen ND
J Am Vet Med Assoc; 2021 Mar; 258(6):648-653. PubMed ID: 33683955
[TBL] [Abstract][Full Text] [Related]
17. Comparing PFGE, MLST, and WGS in monitoring the spread of macrolide and rifampin resistant Rhodococcus equi in horse production.
Álvarez-Narváez S; Logue CM; Barbieri NL; Berghaus LJ; Giguère S
Vet Microbiol; 2020 Mar; 242():108571. PubMed ID: 32122585
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial resistance among
Lord J; Carter C; Smith J; Locke S; Phillips E; Odoi A
PeerJ; 2022; 10():e13682. PubMed ID: 36164606
[TBL] [Abstract][Full Text] [Related]
19. Clostridium difficile associated with acute colitis in mares when their foals are treated with erythromycin and rifampicin for Rhodococcus equi pneumonia.
Båverud V; Franklin A; Gunnarsson A; Gustafsson A; Hellander-Edman A
Equine Vet J; 1998 Nov; 30(6):482-8. PubMed ID: 9844966
[TBL] [Abstract][Full Text] [Related]
20. Development of reactive arthritis and resistance to erythromycin and rifampin in a foal during treatment for Rhodococcus equi pneumonia.
Kenney DG; Robbins SC; Prescott JF; Kaushik A; Baird JD
Equine Vet J; 1994 May; 26(3):246-8. PubMed ID: 8542848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
